Furthermore, GRK6 was successfully inhibited by treatment with GF109206X in vitro, alongside to an inhibition of protein kinase C, leading to cytotoxicity in myeloma cell lines [7]. This evidence concerns the gene GRK6 and plasma cell myeloma.